Transcriptional changes associated with reduced spontaneous liver tumor incidence in mice chronically exposed to high dose arsenic
- PMID: 19822182
- PMCID: PMC7316389
- DOI: 10.1016/j.tox.2009.10.004
Transcriptional changes associated with reduced spontaneous liver tumor incidence in mice chronically exposed to high dose arsenic
Abstract
Exposure of male C3H mice in utero (from gestational days 8-18) to 85ppm sodium arsenite via the dams' drinking water has previously been shown to increase liver tumor incidence by 2 years of age. However, in our companion study (Ahlborn et al., 2009), continuous exposure to 85ppm sodium arsenic (from gestational day 8 to postnatal day 365) did not result in increased tumor incidence, but rather in a significant reduction (0% tumor incidence). The purpose of the present study was to examine the gene expression responses that may lead to the apparent protective effect of continuous arsenic exposure. Genes in many functional categories including cellular growth and proliferation, gene expression, cell death, oxidative stress, protein ubiquitination, and mitochondrial dysfunction were altered by continuous arsenic treatment. Many of these genes are known to be involved in liver cancer. One such gene associated with rodent hepatocarcinogenesis, Scd1, encodes stearoyl-CoA desaturase and was down-regulated by continuous arsenic treatment. An overlap between the genes in our study affected by continuous arsenic exposure and those from the literature affected by long-term caloric restriction suggests that reduction in the spontaneous tumor incidence under both conditions may involve similar gene pathways such as fatty acid metabolism, apoptosis, and stress response.
Conflict of interest statement
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures
Similar articles
-
Transplacental arsenic exposure produced 5-methylcytosine methylation changes and aberrant microRNA expressions in livers of male fetal mice.Toxicology. 2020 Apr 15;435:152409. doi: 10.1016/j.tox.2020.152409. Epub 2020 Feb 14. Toxicology. 2020. PMID: 32068019 Free PMC article.
-
Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure.Environ Health Perspect. 2006 Mar;114(3):404-11. doi: 10.1289/ehp.8534. Environ Health Perspect. 2006. PMID: 16507464 Free PMC article.
-
Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice.Toxicology. 2009 Aug 3;262(2):106-13. doi: 10.1016/j.tox.2009.05.003. Epub 2009 May 18. Toxicology. 2009. PMID: 19450653 Free PMC article.
-
Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation.Toxicology. 2004 May 20;198(1-3):31-8. doi: 10.1016/j.tox.2004.01.017. Toxicology. 2004. PMID: 15138027
-
Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns.J Toxicol Environ Health B Crit Rev. 1998 Jul-Sep;1(3):199-241. doi: 10.1080/10937409809524552. J Toxicol Environ Health B Crit Rev. 1998. PMID: 9644328 Review.
Cited by
-
Lipid Metabolism as a Potential Target of Liver Cancer.J Hepatocell Carcinoma. 2024 Feb 14;11:327-346. doi: 10.2147/JHC.S450423. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 38375401 Free PMC article. Review.
-
Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise.World J Hepatol. 2023 Jan 27;15(1):1-18. doi: 10.4254/wjh.v15.i1.1. World J Hepatol. 2023. PMID: 36744169 Free PMC article. Review.
-
Overcoming the cytoplasmic retention of GDOWN1 modulates global transcription and facilitates stress adaptation.Elife. 2022 Dec 7;11:e79116. doi: 10.7554/eLife.79116. Elife. 2022. PMID: 36476745 Free PMC article.
-
Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma.Mol Biol Rep. 2022 Sep;49(9):8871-8882. doi: 10.1007/s11033-021-07094-2. Epub 2022 Jul 29. Mol Biol Rep. 2022. PMID: 35906508 Review.
-
Aberrant lipid metabolism as a therapeutic target in liver cancer.Expert Opin Ther Targets. 2019 Jun;23(6):473-483. doi: 10.1080/14728222.2019.1615883. Epub 2019 May 10. Expert Opin Ther Targets. 2019. PMID: 31076001 Free PMC article. Review.
References
-
- Amadori S, Fenaux P, Ludwig H, O’dwyer M, Sanz M, 2005. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent. Curr. Med. Res. Opin 21 (3), 403–411. - PubMed
-
- Andrew AS, Bernardo V, Warnke LA, Davey JC, Hampton T, Mason RA, Thorpe JE, Ihnnat MA, Hamilton JW, 2007. Exposure to arsenic at levels found in U.S. drinking water modifies expression in the mouse lung. Toxicol. Sci 100, 75–87. - PubMed
-
- Archer SY, Hodin RA, 1999. Histone acetylation and cancer. Curr. Opin. Genet.Dev 9, 171–174. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources